TG Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for TG Therapeutics (TGTX).

Price Target Range — 10 Quarters

Analyst Consensus — 7 Analysts

5Buy

1Hold

1Sell

Consensus RatingBuy# Analysts7Avg. Consensus PT$51Upside to Avg. PT-14.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 1, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$78
Aug 7, 2026	JP Morgan	Brian Cheng	PT Raise	Overweight	$65→$72
Jul 27, 2026	B. Riley Securities	William Woods	PT Raise	Buy	$55→$86
Jul 13, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$70→$77
Jul 7, 2026	B of A Securities	Alec Stranahan	PT Raise	Underperform	$17→$20
Jul 6, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$70
May 27, 2026	HC Wainwright & Co.	Emily Bodnar	Maintained	Buy	$70
May 6, 2026	HC Wainwright & Co.	Emily Bodnar	PT Raise	Buy	$60→$70
Feb 2, 2026	JP Morgan	Brian Cheng	PT Cut	Overweight	$49→$46
Jan 15, 2026	Goldman Sachs	Corinne Johnson	PT Raise	Neutral	$37→$39
Nov 3, 2025	JP Morgan	Eric Joseph	PT Raise	Overweight	$46→$49
Oct 6, 2025	HC Wainwright & Co.	Emily Bodnar	Assumes	Buy	$60
Sep 17, 2025	B. Riley Securities	Mayank Mamtani	PT Raise	Buy	$53→$55
Mar 4, 2025	HC Wainwright & Co.	Edward White	Maintained	Buy	$55
Jan 15, 2025	HC Wainwright & Co.	Edward White	Maintained	Buy	$55
Nov 25, 2024	JP Morgan	Eric Joseph	PT Raise	Overweight	$30→$43
Nov 5, 2024	HC Wainwright & Co.	Edward White	PT Raise	Buy	$49→$55
Nov 5, 2024	Goldman Sachs	Corinne Jenkins	PT Raise	Neutral	$20→$22
Oct 29, 2024	TD Cowen	Tara Bancroft	Initiate	Buy	$50
Sep 18, 2024	HC Wainwright & Co.	Edward White	Maintained	Buy	$49

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $78 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

JP Morgan analyst Brian Cheng maintains TG Therapeutics (NASDAQ:TGTX) with a Overweight and raises the price target from $65 to $72.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

B. Riley Securities analyst William Woods maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $55 to $86.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

HC Wainwright & Co. analyst Emily Bodnar maintains TG Therapeutics (NASDAQ:TGTX) with a Buy and raises the price target from $70 to $77.

Benzinga Newsdesk

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

B of A Securities analyst Alec Stranahan maintains TG Therapeutics (NASDAQ:TGTX) with a Underperform and raises the price target from $17 to $20.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

HC Wainwright & Co. analyst Emily Bodnar reiterates TG Therapeutics (NASDAQ:TGTX) with a Buy and maintains $70 price target.

Benzinga Newsdesk

TG Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

TG Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

People Also Watch

People Also Watch

TG Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

TG Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PROJP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PROB. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PROHC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PROB of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

PROHC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $78 Price Target

PRO
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $72

PRO
B. Riley Securities Maintains Buy on TG Therapeutics, Raises Price Target to $86

PRO
HC Wainwright & Co. Maintains Buy on TG Therapeutics, Raises Price Target to $77

PRO
B of A Securities Maintains Underperform on TG Therapeutics, Raises Price Target to $20

PRO
HC Wainwright & Co. Reiterates Buy on TG Therapeutics, Maintains $70 Price Target